Robert Brodsky/X
Apr 29, 2026, 17:25
Robert Brodsky: Ravulizumab Appears To Be Safe And Effective In Pregnancy
Robert Brodsky, Chief of Hematology at Johns Hopkins, has shared a post on X about a recent article he and his colleagues co-authored, published in Blood Advances:
”Ravulizumab appears to be safe and effective in pregnancy. We’ve been waiting for this data for a long time.”
Title: Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy
Authors: Britta Höchsmann, Gloria F Gerber, Wilhelm Leopold, Bhumika J Patel, Eleni Gavriilaki, Almut Hefter, Ursula Kalhammer, Sabine Anna Opitz, Astrid Marx-Hoffmann, Daniel B. Knight, Robert A. Brodsky, Anastasia Marvaki, Chrysavgi Lalayanni, Sixten Körper, Daria V. Babushok, Hubert Schrezenmeier

Stay updated on all scientific advances with Hemostasis Today.
Almut Hefter
Anastasia Marvaki
Astrid Marx-Hoffmann
Bhumika J Patel
Britta Höchsmann
Chrysavgi Lalayanni
Daniel B. Knight
Daria V. Babushok
Eleni Gavriilaki
Gloria F. Gerber
Health
Hematology
Hemostasis News
Hemostasis Today
Hubert Schrezenmeier
Medicine
Pregnancy
Ravulizumab
Robert A. Brodsky
Robert Brodsky
Sabine Anna Opitz
Sixten Körper
Ursula Kalhammer
Wilhelm Leopold
-
Apr 29, 2026, 16:53Chokri Ben Lamine: IV Iron Showdown – FCM vs Ferric Derisomaltose vs Iron Dextran
-
Apr 29, 2026, 16:46Deep Vein Thrombosis Risk in Jobs with Prolonged Sitting – NBCA
-
Apr 29, 2026, 16:41Vikramaditya Gangakar: Essential Pharmacy Facts You Should Know About Aspirin
-
Apr 29, 2026, 16:17W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
-
Apr 29, 2026, 16:12Mavis Agnes Kisakye: Concluding a Successful Entrepreneurs Training for Empowering Ptients’ Mothers
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share on Our Chapter Being Published in Medicine Update 2026
-
Apr 29, 2026, 15:46Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
-
Apr 29, 2026, 15:44Sonal Sonu: Securing First Prize in Research Oral Presentation at the CME
-
Apr 29, 2026, 15:43Andrew Shaw: Long COVID First Diagnostic Classification with 69% accuracy